(Q46028084)

18 December 2017

title

Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy. (English)

1 reference

18 December 2017

1 reference

1 reference

9

I Vergote

1 reference

18 December 2017

author name string

E Despierre

1

1 reference

18 December 2017

S Lambrechts

2

1 reference

18 December 2017

K Leunen

3

1 reference

18 December 2017

P Berteloot

4

1 reference

18 December 2017

P Neven

5

1 reference

18 December 2017

F Amant

6

1 reference

18 December 2017

D J O'Shannessy

7

1 reference

18 December 2017

E B Somers

8

1 reference

18 December 2017

language of work or name

English

0 references

publication date

2 April 2013

1 reference

18 December 2017

published in

Gynecologic Oncology

1 reference

18 December 2017

volume

130

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

192-199

1 reference

18 December 2017

The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Role of folate receptor genes in reproduction and related cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Functional folate receptor alpha is elevated in the blood of ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Folate receptor alpha as a tumor target in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Overexpression of folate binding protein in ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Characterization of the human folate receptor alpha via novel antibody-based probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Clinical trials in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

Folate-targeted therapeutic and imaging agents for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.024

10.1016/J.YGYNO.2013.03.024

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017